Patient outcomes vary significantly based on factors your provider can help you understand and address: Starting BMI: Higher starting BMI generally means more total pounds lost (though the percentage tends to be similar across the population) Insulin resistance: Patients with significant insulin resistance common with prediabetes, metabolic syndrome, and in perimenopausal women sometimes respond less strongly to semaglutide
According to incomplete statistical analysis, GLP-1RA not only reduces blood sugar but also decreases weight, lipid levels, cardiovascular risk, and urinary protein excretion, and protects the nervous system ( Studies have shown that with the aging of Chinas population, the risk of chronic multifactor diseases has significantly increased
Results: Glucagon induced 30% weight loss (from 513g to 342g
Nauck M, Stockmann F, Ebert R, Creutzfeldt W: Reduced incretin effect in type 2 (non-insulin-dependent) diabetes
I would just like to get it to 200+ on MK, and I would be pretty happy